dpp 4 inhibitors vs glp 1 agonist do not combine dpp-4 with glp-1 receptor agonists guidance SGLT-2 inhibitors, Newer Pharmacologic Treatment Guide for

Nauck and the other, anonymous reviewer(s) for their contribution to the peer review of this work

Among patients with pre-existing substance use disorder, GLP-1s were tied to fewer hospitalizations, overdoses and deaths related to substance use

Twoyear effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

29 In a systematic review and meta-analysis pooling these and other studies, Amaral et al found that the risk of glaucoma development was lower in patients taking GLP-1 RAs (HR = .71) compared with controls

GLP-1 in normal-weight PCOS Two studies investigated the GLP-1 secretion in normal-weight women with PCOS compared with age- and BMI-matched healthy women [45, 46]